Simultaneous analysis of oral anticancer drugs for renal cell carcinoma in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry-Reference-Cited by-同舟云学术

Simultaneous analysis of oral anticancer drugs for renal cell carcinoma in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry

Published:2018-02-01 Issue:6 Volume:32 Page:e4184
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Takasaki Shinya¹,Tanaka Masaki¹,Kikuchi Masafumi¹,Maekawa Masamitsu¹,Kawasaki Yoshihide²,Ito Akihiro²,Arai Yoichi²,Yamaguchi Hiroaki¹,Mano Nariyasu¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences; Tohoku University Hospital; Sendai Miyagi Japan

2. Department of Urology; Tohoku University Hospital; Sendai Miyagi Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Reference19 articles.

1. Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS;Andriamanana;Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences,2013

2. Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS;Bouchet;Clinica Chimica Acta,2011